Abstract:Objective. Fetal growth restriction (FGR) is a significant contributor to negative pregnancy and postnatal developmental outcomes. Currently, the exact pathological mechanism of FGR remains unknown. This study aims to utilize multiomics sequencing technology to investigate potential relationships among mRNA, gut microbiota, and metabolism in order to establish a theoretical foundation for diagnosing and understanding the molecular mechanisms underlying FGR. Methods. In this study, 11 healthy pregnant women and nine pregnant women with FGR were divided into Control group and FGR group based on the health status. Umbilical cord blood, maternal serum, feces, and placental tissue samples were collected during delivery. RNA sequencing, 16S rRNA sequencing, and metabolomics methods were applied to analyze changes in umbilical cord blood circulating mRNA, fecal microbiota, and metabolites. RT-qPCR, ELISA, or western blot were used to detect the expression of top 5 differential circulating mRNA in neonatal cord blood, maternal serum, or placental tissue samples. Correlation between differential circulating mRNA, microbiota, and metabolites was analyzed by the Spearman coefficient. Results. The top 5 mRNA genes in FGR were altered with the downregulation of TRIM34, DEFA3, DEFA1B, DEFA1, and QPC, and the upregulation of CHPT1, SMOX, FAM83A, GDF15, and NAPG in newborn umbilical cord blood, maternal serum, and placental tissue. The abundance of Bacteroides, Akkermansia, Eubacterium_coprostanoligenes_group, Phascolarctobacterium, Parasutterella, Odoribacter, Lachnospiraceae_UCG_010, and Dielma were significantly enriched in the FGR group. Metabolites such as aspartic acid, methionine, alanine, L-tryptophan, 3-methyl-2-oxovalerate, and ketoleucine showed notable functional alterations. Spearman correlation analysis indicated that metabolites like methionine and alanine, microbiota (Tyzzerella), and circulating mRNA (TRIM34, SMOX, FAM83A, NAPG) might play a role as mediators in the communication between the gut and circulatory system interaction in FGR. Conclusion. Metabolites (METHIONINE, alanine) as well as microbiota (Tyzzerella) and circulating mRNA (TRIM34, SMOX, FAM83A, NAPG) were possible mediators that communicated the interaction between the gut and circulatory systems in FGR.

The Gut Microbiota of Pregnant Rats Alleviates Fetal Growth Restriction by Inhibiting the TLR9/MyD88 Pathway

Gut Microbiota, Inflammation, and Probiotic Supplementation in Fetal Growth Restriction—A Comprehensive Review of Human and Animal Studies

Characteristics of the gut microbiota in pregnant women with fetal growth restriction

The fecal microbiota of gravidas with fetal growth restriction newborns characterized by metagenomic sequencing

Potential Association of Gut Microbial Metabolism and Circulating mRNA Based on Multiomics Sequencing Analysis in Fetal Growth Restriction

Dysfunction of Tregs Contributes to FGR Pathogenesis Via Regulating Smads Signalling Pathway.

Calorie restriction during gestation impacts maternal and offspring fecal microbiome in mice

Fetal growth restriction exhibits various mTOR signaling in different regions of mouse placentas with altered lipid metabolism

Metabolic and fecal microbial changes in adult fetal growth restricted mice

IL-27 Deficiency Inhibits Proliferation and Invasion of Trophoblasts Via the SFRP2/Wnt/β-catenin Pathway in Fetal Growth Restriction.

Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction

Integrated Analysis of Key Genes and Pathways Involved in Fetal Growth Restriction and Their Associations With the Dysregulation of the Maternal Immune System

Probiotic Lactobacillus rhamnosus GR-1 supernatant prevents lipopolysaccharide-induced preterm birth and reduces inflammation in pregnant CD-1 mice

Dysregulation of miRNA–mRNA expression in fetal growth restriction in a caloric restricted mouse model

METTL3 and IGF2BP2 Coordinately Regulate FOSL1 Mrna Via M6a Modification, Suppressing Trophoblast Invasion and Contributing to Fetal Growth Restriction

161: H19 Lncrna Alters Trophoblast Cell Migration and Invasion Through TGF-β Signaling in Placentas with Fetal Growth Restriction

Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade

Decreased PGF May Contribute to Trophoblast Dysfunction in Fetal Growth Restriction.

Alterations in the Gut Microbiome and Metabolisms in Pregnancies with Fetal Growth Restriction

The Placental NLRP3 Inflammasome and Its Downstream Targets, Caspase-1 and Interleukin-6, Are Increased in Human Fetal Growth Restriction: Implications for Aberrant Inflammation-Induced Trophoblast Dysfunction

Proteomics Analysis of Fetal Growth Restriction and Taurine‑treated Fetal Growth Restriction Rat Brain Tissue by 2D DIGE and MALDI‑TOF/TOF MS Analysis.